NeuroBo Pharmaceuticals Stock Quote NRBO - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.36

Bid

2.31

Ask

2.49

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

20.334M

Previous Close

2.36

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

8,616,010

Dividend Yield

PE Ratio

-0.74

Earnings Per Share (EPS)

-3.2

Revenue

Net Profit

-27.59M

NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is ... NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is a proprietary oral niclosamide formulation in development as a treatment for patients with moderate to severe COVID-19. ANA001 is being studied in a 60-subject Phase 2/3 clinical trial conducted at up to 20 clinical sites in the USA. The company's NB-01 candidate has been shown in a Phase 2 study to significantly reduce pain symptoms associated with painful diabetic neuropathy (PDN), with a superior safety profile when compared to currently available treatments. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.neurobopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

NRBO - Frequently Asked Questions (FAQ)

What is the current NeuroBo Pharmaceuticals share price?

The current share price of NeuroBo Pharmaceuticals is $ 2.36

How many NeuroBo Pharmaceuticals shares are in issue?

NeuroBo Pharmaceuticals has 8,616,010 shares in issue

What is the market cap of NeuroBo Pharmaceuticals?

The market capitalisation of NeuroBo Pharmaceuticals is USD 20.33M

What is the 1 year trading range for NeuroBo Pharmaceuticals share price?

NeuroBo Pharmaceuticals has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of NeuroBo Pharmaceuticals?

The price to earnings ratio of NeuroBo Pharmaceuticals is -0.74

What is the reporting currency for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals reports financial results in USD

What is the latest annual profit for NeuroBo Pharmaceuticals?

The latest annual profit of NeuroBo Pharmaceuticals is USD -27.59M

What is the registered address of NeuroBo Pharmaceuticals?

The registered address for NeuroBo Pharmaceuticals is 108 WEST 13TH ST, WILMINGTON, DELAWARE, 19801

What is the NeuroBo Pharmaceuticals website address?

The website address for NeuroBo Pharmaceuticals is www.neurobopharma.com

Which industry sector does NeuroBo Pharmaceuticals operate in?

NeuroBo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TOIIWOncology Institute Inc	$ 0.1698 (171.63%)	323.85k
OMEXOdyssey Marine Exploration Inc	$ 0.860999 (102.16%)	287.46M
CEPCantor Equity Partners Inc	$ 25.00 (51.52%)	53.71M
TMCTMC the Metals Company Inc	$ 3.69 (44.71%)	65.61M
STROSutro Biopharma Inc	$ 1.30 (44.44%)	4.66M
GNLNGreenlane Holdings Inc	$ 0.015 (-93.89%)	391.59M
JZXNJiuzi Holdings Inc	$ 2.3001 (-68.92%)	2.3M
OCEAOcean Biomedical Inc	$ 0.0098 (-52.20%)	91.42M
INTSIntesity Therapeutics Inc	$ 0.8799 (-32.32%)	846.2k
AGMHAGM Group Holdings Inc	$ 0.0395 (-31.90%)	33.28M
GNLNGreenlane Holdings Inc	$ 0.015 (-93.89%)	391.59M
DMNDamon Inc	$ 0.0036 (-12.20%)	357.1M
OMEXOdyssey Marine Exploration Inc	$ 0.860999 (102.16%)	287.46M
NVDANVIDIA Corporation	$ 106.43 (3.62%)	220.81M
LRHCLa Rosa Holdings Corporation	$ 0.1581 (29.48%)	171.65M